Free Trial
NASDAQ:QURE

uniQure (QURE) Stock Price, News & Analysis

uniQure logo
$54.92 +0.42 (+0.77%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$55.90 +0.98 (+1.79%)
As of 05:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About uniQure Stock (NASDAQ:QURE)

Advanced

Key Stats

Today's Range
$54.50
$57.57
50-Day Range
$13.28
$59.40
52-Week Range
$4.82
$60.70
Volume
2.80 million shs
Average Volume
6.97 million shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$68.42
Consensus Rating
Moderate Buy

Company Overview

uniQure Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

QURE MarketRank™: 

uniQure scored higher than 68% of companies evaluated by MarketBeat, and ranked 321st out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    uniQure has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 9 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    uniQure has a consensus price target of $68.42, representing about 24.6% upside from its current price of $54.92.

  • Amount of Analyst Coverage

    uniQure has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about uniQure's stock forecast and price target.
  • Earnings Growth

    Earnings for uniQure are expected to grow in the coming year, from ($3.75) to ($3.10) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of uniQure is -14.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of uniQure is -14.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about uniQure's valuation and earnings.
  • Percentage of Shares Shorted

    15.07% of the outstanding shares of uniQure have been sold short.
  • Short Interest Ratio / Days to Cover

    uniQure has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in uniQure has recently decreased by 8.72%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    uniQure does not currently pay a dividend.

  • Dividend Growth

    uniQure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    15.07% of the outstanding shares of uniQure have been sold short.
  • Short Interest Ratio / Days to Cover

    uniQure has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in uniQure has recently decreased by 8.72%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for uniQure this week, compared to 1 article on an average week.
  • Search Interest

    78 people have searched for QURE on MarketBeat in the last 30 days. This is an increase of 290% compared to the previous 30 days.
  • MarketBeat Follows

    14 people have added uniQure to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, uniQure insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,328,181.00 in company stock.

  • Percentage Held by Insiders

    Only 4.79% of the stock of uniQure is held by insiders.

  • Percentage Held by Institutions

    78.83% of the stock of uniQure is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about uniQure's insider trading history.
Receive QURE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for uniQure and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

QURE Stock News Headlines

William Blair Analysts Lift Earnings Estimates for uniQure
uniQure FY2025 EPS Estimate Reduced by Cantor Fitzgerald
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.tc pixel
See More Headlines

QURE Stock Analysis - Frequently Asked Questions

uniQure's stock was trading at $17.66 at the beginning of 2025. Since then, QURE shares have increased by 211.0% and is now trading at $54.92.

uniQure N.V. (NASDAQ:QURE) released its quarterly earnings data on Tuesday, July, 29th. The biotechnology company reported ($0.69) EPS for the quarter, topping the consensus estimate of ($0.89) by $0.20. The biotechnology company had revenue of $5.26 million for the quarter, compared to analyst estimates of $5 million. uniQure had a negative trailing twelve-month return on equity of 1,010.74% and a negative net margin of 1,387.98%.
Read the conference call transcript
.

Shares of QURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that uniQure investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
7/29/2025
Today
10/05/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QURE
CIK
1590560
Employees
500
Year Founded
1868

Price Target and Rating

High Price Target
$95.00
Low Price Target
$24.00
Potential Upside/Downside
+24.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$239.56 million
Net Margins
-1,387.98%
Pretax Margin
-1,375.80%
Return on Equity
-1,010.74%
Return on Assets
-33.27%

Debt

Debt-to-Equity Ratio
1.53
Current Ratio
9.98
Quick Ratio
9.98

Sales & Book Value

Annual Sales
$27.12 million
Price / Sales
111.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.14) per share
Price / Book
-392.29

Miscellaneous

Outstanding Shares
54,870,000
Free Float
52,239,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
0.56

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:QURE) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners